Search results for "Chloride"

showing 10 items of 1691 documents

Tris(cyclo-hexyl-ammonium) cis-di-chlorido-bis-(oxalato-κ(2) O (1),O (2))stann-ate(IV) chloride monohydrate.

2013

The crystal structure of the title compound, (C6H14N)3[Sn(C2O4)2Cl2]Cl·H2O, contains three cyclohexylammonium cations, one stannate(IV) dianion, one isolated chloride anion and one lattice water molecule. The cyclohexylammonium cations adopt chair conformations. In the complex anion, two bidentate oxalate ligands and two chloride anions incispositions coordinate octahedrally to the central SnIVatom. The cohesion of the molecular entities is ensured by the formation of N—H...O, O—H...O, O—H...Cl and N—H...Cl interactions involving cations, anions and the lattice water molecule, giving rise to a layer-like arrangement parallel to (010).

TrisMetal-Organic PapersDenticityStannateGeneral ChemistryCrystal structureCondensed Matter PhysicsBioinformaticsMedicinal chemistryChlorideOxalateIonchemistry.chemical_compoundchemistrymedicineGeneral Materials ScienceAmmoniummedicine.drugActa crystallographica. Section E, Structure reports online
researchProduct

ChemInform Abstract: SYNTHESIS OF THE GLYCOPEPTIDE PARTIAL SEQUENCE A80-A84 OF HUMAN FIBROBLAST INTERFERON

1985

The glycopentapeptide H-(GlcNAcβ1-)Asn-Glu-Thr-Ile-Val-OH (10) representing the partial sequence A80–A84 of human fibroblast interferon was synthesized using the newly developed allyl-ester protection of carboxy functions. The allyl esters, which are stable to acids and to bases, can be cleaved under very mild, neutral conditions using tris(triphenylphosphine)rhodium(I) chloride or tetrakis(triphenylphosphine)palladium(0) as a catalyst. This synthetic method opens up a preparative route to glycopeptide model structures of glycoproteins of high biological interest.

TrisStereochemistryChemistryfood and beverageschemistry.chemical_elementSequence (biology)General MedicineChlorideGlycopeptideRhodiumCatalysischemistry.chemical_compoundmedicineTriphenylphosphinemedicine.drugPalladiumChemischer Informationsdienst
researchProduct

Switch between tyrosinase and catecholoxidase activity of scorpion hemocyanin by allosteric effectors

2008

AbstractPhenoloxidases and hemocyanins have similar type 3 copper centers although they perform different functions. Hemocyanins are oxygen carriers, while phenoloxidases (tyrosinase/catecholoxidase) catalyze the initial step in melanin synthesis. Tyrosinases catalyze two subsequent reactions, whereas catecholoxidases catalyze only the second one. Recent results indicate that hemocyanins can also function as phenoloxidases and here we show for the first time that hemocyanin can be converted to phenoloxidase. Furthermore, its substrate specificity can be switched between catecholoxidase and tyrosinase activity depending on effectors such as hydroxymethyl-aminomethan (Tris) and Mg2+-ions. Thi…

TrisStereochemistrymedicine.medical_treatmentTyrosinaseDopamineAllosteric regulationActivated hemocyaninBiophysicsMagnesium ChlorideTyramineType 3 copper proteinchemical and pharmacologic phenomenaBiochemistryCatalysisSubstrate SpecificityScorpionschemistry.chemical_compoundEnzyme activatorAllosteric RegulationStructural BiologyHemolymphHemolymphGeneticsmedicineAnimalsCatechol oxidaseMolecular BiologyScorpion Pandinus imperatorbiologyMonophenol MonooxygenaseSpectrum AnalysisActive siteCatecholoxidaseHemocyaninCell BiologyEnzyme ActivationchemistryBiochemistryHemocyaninsbiology.proteinTyrosinaseCatechol OxidaseFEBS Letters
researchProduct

Synthesis, structural studies and reactivity of vanadium complexes with tridentate (OSO) ligand

2007

The direct reaction between [VCl(3)(thf)3] or [VO(OEt)3] and 2,2'-thiobis{4-(1,1,3,3-tetramethyl-butyl)phenol (tbopH(2)) leads to the formation of [V(2)(micro-tbop-kappa(3)O,S,O)2Cl(2)(CH(3)CN)(2)] (1).4CH(3)CN or [V(2)(micro-OEt)2(O)2(tbop-kappa(3)O,S,O)2] (2), respectively, in high yield. Compounds 1 and 2 were characterized by chemical and physical techniques including X-ray crystallography and variable temperature magnetic susceptibility studies (J = -29.1 cm(-1)) for 1. Complexes 1 and 2 were supported on MgCl2 and when activated with aluminium alkyls, were found to effectively polymerize ethene to produce polyethylene with a narrow molecular weight distribution M(w)/M(n) approximately…

Vanadium CompoundsLigandStereochemistrySpectrum AnalysisMagnesium ChlorideTemperatureVanadiumchemistry.chemical_elementCrystallography X-RayLigandsMedicinal chemistryMagnetic susceptibilityCatalysisCatalysisMolecular WeightInorganic ChemistrychemistryPolymerizationPolyethyleneYield (chemistry)NitrogenaseAluminum OxideOrganometallic CompoundsMolar mass distributionReactivity (chemistry)Dalton Trans.
researchProduct

Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma.

2020

Abstract Progression on therapy in non-small cell lung carcinoma (NSCLC) is often evaluated radiographically, however, image-based evaluation of said therapies may not distinguish disease progression due to intrinsic tumor drug resistance or inefficient tumor penetration of the drugs. Here we report that the inhibition of mutated EGFR promotes the secretion of a potent vasoconstrictor, endothelin-1 (EDN1), which continues to increase as the cells become resistant with a mesenchymal phenotype. As EDN1 and its receptor (EDNR) is linked to cancer progression, EDNR-antagonists have been evaluated in several clinical trials with disappointing results. These trials were based on a hypothesis that…

Vascular Endothelial Growth Factor ACancer ResearchLung NeoplasmsAmbrisentanOncology and CarcinogenesisDrug ResistanceBiological AvailabilityAntineoplastic AgentsDrug resistanceCell LineMiceErlotinib HydrochlorideGefitinibIn vivomedicineAnimalsHumansOncology & CarcinogenesisNon-Small-Cell LungProtein Kinase InhibitorsLungCancerTumor microenvironmentTumorEndothelin-1business.industryCarcinomaLung CancerCancerEvaluation of treatments and therapeutic interventionsGefitinibmedicine.diseaseEndothelin 1Xenograft Model Antitumor AssaysErbB ReceptorsOncologyVasoconstriction5.1 Pharmaceuticals6.1 PharmaceuticalsCancer cellMutationCancer researchNeoplasmDevelopment of treatments and therapeutic interventionsbusinessmedicine.drug
researchProduct

Interference of tributyltin(IV)chloride on the vascular plant cells

2007

In the recent past years, interest in the environmental impact of organotin(IV) compounds has risen markedly. Considering that most data in the scientific literature refers to the animal kingdom and not to higher plants cells, we tested the effects of organotin compounds on vascular plant cells, by studying the interaction of tributyltin chloride (TBTCl) with Allium cepa, Solanun tuberosum and Solanum melongena, vascular plants that are directly involved in the human food chain. The TBTCl effects on mitotic metaphase plates, on pollen grains and on both microtubers and adult tuber parenchymatic cells were investigated and the concentrations of TBTCl inside the treated parenchymatic cells we…

Vascular plantAllium cepabiologyfood and beveragesGeneral Chemistrybiology.organism_classificationmedicine.disease_causeChlorideIncubation periodInorganic Chemistrychemistry.chemical_compoundchemistryChlorophyllPollenmedicineTributyltinAlliumTBTSolanun tuberosumchlorophyllFood scienceSolanumoxygenSolanun melongenamedicine.drugApplied Organometallic Chemistry
researchProduct

Flexibilität und thermodynamisches Verhalten von isotaktischem und syndiotaktischem Polymethylmethacrylat

1964

An den beiden taktischen Formen des Polymethylmethacrylats werden Viskositatsmessungen und Lichtstreuungsmessungen gemacht, um Knaueldimensionen und Unterschiede im thermodynamischen Verhalten zu ermitteln. Die isotaktische Form hat in allen Losungsmitteln die grosere Persistenzlange. Die Thetapunkte beider Formen sind verschieden, Wobei es vom Losungsmittel Abhangt, welche Form den hoheren Thetapunkt hat. Der 2. osmotische Virialkoeffizient in Butylchlorid verhalt sich fur beide Formen “normal”. Im Losungsmittelgemisch Butanon-Isopropanol zeigen sich extreme Unterschiede zwischen der isotaktischen und der syndiotaktischen Form. Measurements of viscosity and light scattering are made on the…

Virial coefficientChemistryPolymer chemistryButyl chlorideDie Makromolekulare Chemie
researchProduct

Effects of a vitamin D3 analogue in a rat model of bladder outlet obstruction

2006

OBJECTIVES To explore the effect of the vitamin D3 analogue, BXL-628, on some of the consequences of bladder outlet obstruction (BOO), e.g. hypertrophy and loss of contractile function, as vitamin D3 and BXL-628 inhibit prostate and bladder cell growth in vitro, and there are receptors for vitamin D in rat and human bladder. MATERIAL AND METHODS In female rats, BOO was produced by a standardized method; one group received daily BXL-628 (150 µg/kg per day) and the remaining rats received vehicle. Sham-operated rats received BXL-628 or vehicle. After 2 weeks, the conscious rats were assessed by cystometry. Plasma calcium levels were determined and in vitro contractility assessed at the end of…

Vitaminmedicine.medical_specialtyUrologymedia_common.quotation_subjectUrinary BladderUrinationStimulationurologic and male genital diseasesUrinationPotassium ChlorideMuscle hypertrophyRats Sprague-DawleyContractilityBladder outlet obstructionchemistry.chemical_compoundCalcitriolInternal medicinePressuremedicineVitamin D and neurologyAnimalsmedia_commonmedicine.diagnostic_testbusiness.industryCystometryHypertrophyOrgan SizeElectric StimulationRatsUrinary Bladder Neck ObstructionEndocrinologychemistryFemalebusinessMuscle ContractionBJU International
researchProduct

Dismantling and copper recovery from Waste Printed Circuit Boards (WPCBs) using an integrated hydro-electrometallurgical approach

Waste Printed circuit boards copper recovery chloride-sulphate solution electrochemical recovering circular economy
researchProduct

Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein.

2021

Cystic fibrosis (CF) is a genetic disease caused by mutations that impair the function of the CFTR chloride channel. The most frequent mutation, F508del, causes misfolding and premature degradation of CFTR protein. This defect can be overcome with pharmacological agents named “correctors”. So far, at least three different classes of correctors have been identified based on the additive/synergistic effects that are obtained when compounds of different classes are combined together. The development of class 2 correctors has lagged behind that of compounds belonging to the other classes. It was shown that the efficacy of the prototypical class 2 corrector, the bithiazole corr-4a, could be impr…

Yellow fluorescent proteinProtein FoldingCystic FibrosisMutantPharmaceutical ScienceCystic Fibrosis Transmembrane Conductance RegulatorCarboxamidemedicine.disease_cause01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundMutant ProteinDrug DiscoveryMoietyCFTR potentiatorCFTRchemistry.chemical_classification0303 health sciencesMutationbiologyChemistryChemistry (miscellaneous)Chloride channelMolecular MedicineHumanStereochemistrymedicine.drug_classCFTR correctorArticleF508del-CFTRlcsh:QD241-44103 medical and health scienceslcsh:Organic chemistrymedicineHumansBenzodioxolesPhysical and Theoretical ChemistryThiazoleCystic Fibrosi030304 developmental biology010405 organic chemistryOrganic ChemistryAminoimidazole Carboxamide0104 chemical sciencesThiazolesMutationbiology.proteinMutant ProteinsBenzodioxoleTricyclicMolecules (Basel, Switzerland)
researchProduct